Lactobacillus coryniformis causing pulmonary infection in a patient with metastatic small cell carcinoma: Case report and review of literature on Lactobacillus pleuro-pulmonary infections

Journal of Clinical and Diagnostic Research

Volumn 11, Issue 2, 2017, Pages DE01-DE05

  Datta, Priya ^a   Gupta, Varsha ^a   Mohi, Gursimran Kaur ^a   Chander, Jagdish ^a   Janmeja, Ashok Kumar ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Ampicillin; Bacteraemia; Commensals; Immunosuppression

Indexed keywords

AMPICILLIN; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; DEXAMETHASONE; ERYTHROMYCIN; GENTAMICIN; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ABNORMAL RESPIRATORY SOUND; ADULT; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CASE REPORT; CERVICAL LYMPH NODE; CERVICAL LYMPHADENOPATHY; COMPUTER ASSISTED TOMOGRAPHY; FINE NEEDLE ASPIRATION BIOPSY; HEPATOMEGALY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LACTOBACILLUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS RHAMNOSUS; LUNG INFECTION; LYMPH NODE METASTASIS; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MIDDLE AGED; NONHUMAN; PLEURA EFFUSION; REVIEW; SMALL CELL CARCINOMA; THORAX RADIOGRAPHY;

EID: 85011843537     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2017/22837.9391     Document Type: Review

References (36)

1. th edn. Churchill Livingstone, 1996. pp 449- 66.
2. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility; twenty-fifth informational supplement. CLSI document M100-S25 Clinical and laboratory standards institute, Wayne, Pennsylvania, USA. 2015 35:3.
3. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, WC (1992) Diagnostic microbiology. J.B. Lippincott Company, Philadelphia, pp 433–445, 484–486.
4. th ed. Washington, DC: ASM Press, 1995:5–18.
5. Sussman JI, Baron EJ, Goldberg SM. Clinical manifestations and therapy of Lactobacillus endocarditis: report of a case and a review of the literature. Rev Infect Dis. 1986;8:771–76.
6. Antony S. Lactobacillemia: an emerging cause of infection in both the Immunocompromised and the immunocompetent host. J Natl Med Assoc. 2000;92:83-6.
7. Rahman M. Chest infection caused by Lactobacillus casei ss rhamnosus. Br Med J. 1982;284:471–72.
8. Querol JM, Manresa F, Izquierdo J, Cisnal M. Lactobacillus pneumonia in a patient with oesophageal carcinoma. Eur Respir J. 1989;2:589–91.
9. Namnyak SS, Blair ALT, Hughes DF, McElhinney P, Donnelly MR, Corey J. Fatal lung abscess due to Lactobacillus casei ss rhamnosus. Thorax. 1992;47:666– 67.
10. Sriskandan S, Lacey S, Fischer L. Isolation of vancomycin resistant lactobacilli from three neutropenic patients with pneumonia. Eur J Clin Microbiol Infect Dis. 1993;12:649–50.
11. Jones SD, Fullerton DA, Zamora MR, Badesch DB, Campbell DN, Griver FL. Transmission of Lactobacillus pneumonia by a transplanted lung. Ann Thorac Surg. 1994;58:887-89.
12. Fruchart C, Salah A, Gray C, Martin E, Stamatoullas A, Bonmarchand G, et al. Lactobacillus species as emerging pathogens in neutropenic patients. Eur J Clin Microbiol Infect Dis. 1997;16:681–84.
13. Abgrall S, Joly V, Derkinderen P, Decré D, Carbon C, Yeni P. Lactobacillus casei infection in an AIDS patient [letter]. Eur J Clin Microbiol Infect Dis. 1997;16:180– 82.
14. Rogasi PG, Vigano S, Pecile P, Leoncini F. Lactobacillus casei pneumonia and sepsis in a patient with AIDS. Case report and review of the literature. Ann Ital Med Int. 1998;13:180–82.
15. Wood GC, Boucher BA, Croce MA, Fabian TC. Lactobacillus species as a cause of ventilator–associated pneumonia in a critically ill trauma patient. Pharmacotherapy. 2002;22(9):1180-82.
16. Doern CD, Nguyen SR, Afolabi F, Burnham CA. Probiotics –associated aspiration pneumonia due to Lactobacillus rhamnosus. J Clin Microbiol. 2014;52(8):3124-26.
17. Querol JM, Manresa F, Barbe F, Cisnal M. Lactobacilli and pleuropulmonary infection. Eur Resp J. 1989;2:1021-22.
18. Sharpe ME, Hill LR, Lapage SP. Pathogenic lactobacilli. J Med Microbiol. 1973;6:281–86.
19. Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteraemia and endocarditis: review of 45 cases. Clin Infect Dis. 1997;25:1048–55.
20. Cannon JP, Lee TA, Bolanos JT, Danzinger LH. Pathogenic relevance of Lactobacillus: a retrospective review of over 22 cases. Eur J Clin Microbiol Infect Dis. 2005;24:31-40.
21. Antony S, Dummer S, Stratton C. Lactobacillus bacteraemia and endocarditis. Clin Infect Dis. 1998;26:1483–84.
22. Antony SJ, Stratton CW, Dummer JS. Lactobacillus bacteraemia: description of the clinical course in adult patients without endocarditis. Clin Infect Dis. 1996;23:773–78.
23. Murray PR, Baron E, Jorgenson JH, Pfaller MA, Yolken RH. Manual of clinical microbiology. ASM Press, Washington DC. 2003. Pp. 857, 869.
24. Gallemore GH, Mohon RT, Ferguson DA. Lactobacillus fermentum endocarditis involving a native mitral valve. J Tenn Medical Assoc. 1995;88:306–08.
25. Oakey HJ, Harty DWS, Know KW. Enzyme production by lactobacilli and the potential link with infective endocarditis. J Appl Bacteriol. 1995;78:142–48.
26. Harty DWS, Oakey HJ, Patrikakis M, Hume EBH, Knox KW. Pathogenic potential of lactobacilli. Int J Food Microbiol. 1994;24:179–89.
27. Harty DWS, Patrikakis M, Knox KW. Identification of Lactobacillus strains from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same species. Microb Ecol Health Dis. 1993;6:191–201.
28. Harty DWS, Patrikakis M, Hume EBH, Oakey HJ, Knox KW. The aggregation of human platelets by Lactobacillus species. J Gen Microbiol. 1993;139:2945–41.
29. Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, et al. Lactobacillus bacteraemia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 2004;38:62–9.
30. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 2005;115:178–81.
31. Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteraemia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr. 2004;38:457–58.
32. Mackay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin Microbiol Infect. 1999;5:290–92.
33. Kochan P, Chmielarczyk A, Szymaniak L, Brykczynski M, Galant K, Zych A, et al. Lactobacillus rhamnosus administration causes sepsis in a cardio surgical patient—is the time right to revise probiotics safety guidelines? Clin Microbiol Infect. 2011;17:1589–92.
34. Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrup DM, Keating MR. Lactobacillemia in liver transplant patients. Clin Infect Dis. 1994;18:207–12.
35. Toporoff B, Rosado LJ, Appleton CP, Sethi GK, Copeland JG. Successful treatment of early infective endocarditis and mediastinitis in a heart transplant recipient. J Heart Lung Transplant. 1994;13:546–48.
36. Swenson JM, Facklam RR, Thornsberry C. Antimicrobial susceptibility of vancomycin resistant Leuconostoc, Pediococcus, and Lactobacillus species. Antimicrob Agents Chemother. 1990;34:543–49.